Literature DB >> 12882722

How do transurethral needle ablation of the prostate and transurethral microwave thermotherapy compare with transurethral prostatectomy?

Ricardo R Gonzalez1, Alexis E Te.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12882722     DOI： 10.1007/s11934-003-0088-x

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   2.862


× No keyword cloud information.
  49 in total

Review 1.  Microwave thermotherapy for the treatment of benign prostatic hyperplasia.

Authors:  M L Blute
Journal:  Semin Urol       Date:  1994-08

2.  High energy thermotherapy versus transurethral resection in the treatment of benign prostatic hyperplasia: results of a prospective randomized study with 1 year of followup.

Authors:  F C D'Ancona; E A Francisca; W P Witjes; L Welling; F M Debruyne; J J de la Rosette
Journal:  J Urol       Date:  1997-07       Impact factor: 7.450

3.  Baseline prostatic specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy.

Authors:  M Pilar Laguna; Lambertus A Kiemeney; Frans M J Debruyne; Jean J M C H de la Rosette
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

4.  The assessment of prostatic obstruction from urodynamic measurements and from residual urine.

Authors:  P H Abrams; D J Griffiths
Journal:  Br J Urol       Date:  1979-04

5.  Detailed interstitial temperature mapping during treatment with a novel transurethral microwave thermoablation system in patients with benign prostatic hyperplasia.

Authors:  T R Larson; J M Collins; A Corica
Journal:  J Urol       Date:  1998-01       Impact factor: 7.450

6.  Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study.

Authors:  C G Roehrborn; M M Issa; R C Bruskewitz; M J Naslund; J E Oesterling; R Perez-Marrero; B P Shumaker; P Narayan
Journal:  Urology       Date:  1998-03       Impact factor: 2.649

7.  Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction.

Authors:  D J Rosario; H Woo; K L Potts; P E Cutinha; K J Hastie; C R Chapple
Journal:  Br J Urol       Date:  1997-10

8.  Cost effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapy.

Authors:  Michael J Manyak; Stacey J Ackerman; Michael L Blute; Alison L Rein; Kathleen Buesterien; Erin M Sullivan; Craig P Tanio; Michael J Strauss
Journal:  J Endourol       Date:  2002-02       Impact factor: 2.942

9.  Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months.

Authors:  B Djavan; C Seitz; C G Roehrborn; M Remzi; M Fakhari; M Waldert; A Basharkhah; B Planz; M Harik; M Marberger
Journal:  Urology       Date:  2001-01       Impact factor: 2.649

10.  Temperature-correlated histopathologic changes following microwave thermoablation of obstructive tissue in patients with benign prostatic hyperplasia.

Authors:  T R Larson; D G Bostwick; A Corica
Journal:  Urology       Date:  1996-04       Impact factor: 2.649
View more
  2 in total

Review 1.  Transurethral microwave thermotherapy for the treatment of BPH: still a challenger?

Authors:  T R W Herrmann; A J Gross; D Schultheiss; P M Kaufmann; U Jonas; M Burchardt
Journal:  World J Urol       Date:  2006-06-03       Impact factor: 4.226

Review 2.  First-line treatment for symptomatic benign prostatic hyperplasia: is there a particular patient profile for a particular treatment?

Authors:  Ricardo R Gonzalez; Steven A Kaplan
Journal:  World J Urol       Date:  2006-05-19       Impact factor: 4.226
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.